Purchase Order 75H70926P00023
- Not listed
- The Indian Health Service (IHS) awarded a $45,900 firm fixed-price purchase order to Cepheid Inc. on December 1, 2025, for molecular diagnostic solutions with a completion date of November 30, 2030. The contract, which carries no set-aside designation, will be performed in Tohatchi, New Mexico. Cepheid, a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, will deliver diagnostic testing capabilities to support IHS healthcare operations. The company...
- The Indian Health Service awarded a purchase order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on October 16, 2025. The contract, valued at $260,025, runs from October 19, 2025, through October 18, 2026, with an ultimate completion date of October 18, 2030. Utilizing firm fixed-price pricing with no set-aside designation, this purchase order will be performed in Parker, Arizona, and represents one of five related contract actions awarded under...
- The U.S. Indian Health Service awarded a $168,475.00 firm fixed-price purchase order contract to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract is for the administrative modification to extend the period of performance to December 31, 2025. Cepheid provides comprehensive molecular diagnostic technologies to various federal agencies, including the Department of Veterans Affairs (VA), Indian Health Service (IHS), and Defense...
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a delivery order valued at $242,163.20 by the Indian Health Service (IHS) for Option Year Two of a contract covering laboratory supplies and testing services. The award, issued on July 2, 2024, covers the period from September 1, 2024, through August 31, 2025, with an ultimate completion date of August 31, 2028. The contract utilizes a firm fixed-price pricing model with no set-aside designation and is...
- The U.S. Indian Health Service (IHS) awarded a $115,600.00 firm fixed-price purchase order contract to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, for the provision of CEPHEID TEST KITS. The contract has an ultimate completion date of July 10, 2025 and was awarded on January 30, 2024. Cepheid is a prime contractor that provides advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing to various federal agencies,...
- The Department of Health and Human Services Indian Health Service has awarded a $19,206.10 firm-fixed-price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. This contract does not have a set-aside designation. Cepheid will provide diagnostic testing equipment, reagents, consumables, and associated maintenance and support services to support the Indian Health Service's clinical testing programs. Cepheid is a leading provider of molecular diagnostics...
- This is a federal contract awarded by the Indian Health Service (IHS), a civilian agency, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract is a delivery order worth $199,060.08 with a performance period from July 1, 2025 to June 30, 2026. It is a firm fixed-price contract with no set-aside designation. The contract requires Cepheid to provide GeneXpert diagnostic systems, molecular reagents, test kits, and associated...
- This is a firm fixed-price delivery order awarded by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The $14,564 award funds Cepheid's provision of diagnostics equipment, reagents, consumables, and associated maintenance and support services to IHS. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract between Cepheid and IHS....
- This is a firm fixed-price purchase order awarded by the Indian Health Service, a civilian federal agency, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The $59,235.71 contract is for the provision of Combined Cepheid Service, with an ultimate completion date of January 31, 2030. Cepheid is an experienced federal contractor, holding several significant Indefinite Delivery Vehicle (IDV) contracts with agencies such as the Department of...
- Cepheid has been awarded a $57,739.26 firm fixed price delivery order by the Department of Health and Human Services Indian Health Service (IHS) for the period of September 1, 2022 through August 31, 2023. This order is being issued against an existing IHS base contract held by Cepheid, and provides for the delivery of products and services in support of IHS clinical diagnostic programs, consistent with the terms and conditions of the underlying vehicle. As the original equipment manufacturer,...
The Indian Health Service (IHS) has awarded a $28.3K purchase order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with a performance deadline of December 10, 2030. This firm fixed-price contract, designated as the FPSU CEPHEID SERVICE AGREEMENT BASE +4, contains no set-aside provisions and will be performed in Poplar, Montana. The award follows Cepheid's established track record of providing advanced diagnostic systems and testing solutions to federal healthcare agencies, including the Department of Veterans Affairs and the Defense Logistics Agency, focusing on molecular diagnostic equipment, reagents, and maintenance services. This purchase order enables IHS to procure Cepheid's GeneXpert diagnostic systems and associated molecular testing capabilities, consistent with the company's core offerings for detecting infectious diseases and clinical conditions. The relatively modest ceiling value reflects a targeted procurement likely supporting a specific clinical testing need at the Poplar facility. Cepheid's broader federal portfolio includes two significant Indefinite Delivery Vehicle contracts with the VA, valued at approximately $35.3M combined, underscoring the company's substantial presence in federal molecular diagnostics procurement and its demonstrated capability to support IHS and other government health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 12/9/25 |